OppenheimerFunds’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-25,674
Closed -$775K 1799
2016
Q2
$775K Buy
+25,674
New +$521K ﹤0.01% 1076

OppenheimerFunds's CPXX Position: Q3 2016 in Review

OppenheimerFunds sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 25,674 shares — an estimated $775K sold.

OppenheimerFunds first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $775K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • OppenheimerFunds reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • OppenheimerFunds sold 25,674 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $775K.
  • OppenheimerFunds first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • OppenheimerFunds's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $775K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.